Catch-up Growth in Prepubertal Children Treated for Juvenile Hypothyroidism and Growth Hormone Deficiency can be Modelled with a Monomolecular Function


Journal

Journal of clinical research in pediatric endocrinology
ISSN: 1308-5735
Titre abrégé: J Clin Res Pediatr Endocrinol
Pays: Turkey
ID NLM: 101519456

Informations de publication

Date de publication:
26 02 2021
Historique:
entrez: 16 9 2020
pubmed: 17 9 2020
medline: 3 11 2021
Statut: ppublish

Résumé

We hypothesized that modelling catch-up growth (CUG) as developed for coeliac disease (CD), might also fit CUG in adequately treated children with juvenile hypothyroidism (JHT) or growth hormone deficiency (GHD). We used a monomolecular function for all available prepubertal data on height standard deviation score (HSDS) minus target height SDS (adjHSDS) in children with JHT (n=20) and GHD (n=18) on a conventional (CoD) or high GH dose (HD), based either on a national height reference with an age cut-off of 10 (girls) and 12 (boys) years (model 1) or prepubertal height reference values, if age (0) was ≥3, with no upper age limit (model 2). The models could be fitted in 83-90% of cases; in other cases the HSDS decreased after several measurements, which violated the assumption of an irreversible growth process. In JHT, the rate constant (k) and adjHSDS (0) were lower than in CD (p=0.02), but adjHSDS (end) was similar. In GHD (model 1), k was lower than for CD (p=0.004) but similar to JHT, while adjHSDS (0) and adjHSDS (end) were similar to CD and JHT. Thus, the shape of CUG is similar for children with JHT and GHD, while children with CD had less growth deficit at start and a faster CUG. The differences in CUG parameters between GH dose subgroups did not reach statistical significance. Modelling CUG of prepubertal children with JHT and GHD can be used for assessing the adequacy of CUG and the influence of clinical treatment modalities on its speed and magnitude.

Identifiants

pubmed: 32936765
doi: 10.4274/jcrpe.galenos.2020.2020.0130
pmc: PMC7947729
doi:

Substances chimiques

Human Growth Hormone 12629-01-5

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

15-22

Références

Horm Res. 2003;60(Suppl 1):27-35
pubmed: 12955015
Nature. 1963 Aug 31;199:845-50
pubmed: 14079891
Horm Res Paediatr. 2010;74(3):172-81
pubmed: 20424418
Arch Dis Child. 1966 Dec;41(220):613-35
pubmed: 5927918
Nutrients. 2015 Jan 14;7(1):517-51
pubmed: 25594438
Pediatr Res. 2000 Mar;47(3):316-23
pubmed: 10709729
Am J Hum Biol. 2011 Nov-Dec;23(6):764-73
pubmed: 21957002
Growth Horm IGF Res. 2009 Feb;19(1):1-11
pubmed: 18824380
Horm Res. 1998;50(5):264-70
pubmed: 9873194
J Pediatr. 1963 May;62:646-59
pubmed: 13985887
J Clin Endocrinol Metab. 2010 Mar;95(3):1229-37
pubmed: 20097713
PLoS One. 2018 Oct 24;13(10):e0206009
pubmed: 30356273
Arch Dis Child. 1966 Oct;41(219):454-71
pubmed: 5957718
Endocr Rev. 1997 Oct;18(5):646-61
pubmed: 9331546
N Engl J Med. 1988 Mar 10;318(10):599-602
pubmed: 3344006
Nestle Nutr Inst Workshop Ser. 2015;81:87-97
pubmed: 26111566
Horm Res Paediatr. 2011;75(6):423-32
pubmed: 21358173
J Pediatr Endocrinol Metab. 2002 Dec;15 Suppl 5:1229-41
pubmed: 12510974
J Pediatr. 2005 Dec;147(6):843-6
pubmed: 16356444
J Embryol Exp Morphol. 1981 Oct;65 Suppl:89-101
pubmed: 7334313
Horm Res. 2002;57 Suppl 2:66-70
pubmed: 12065931
Pediatr Res. 1974 Mar;8(3):149-56
pubmed: 4815828
Endocrinology. 1994 Oct;135(4):1367-71
pubmed: 7925098
J Pediatr. 2013 Feb;162(2):415-20
pubmed: 23153864
Acta Paediatr. 1994 Oct;83(10):1097-9
pubmed: 7841713
Eur J Pediatr. 1996 May;155(5):362-7
pubmed: 8741031
J Clin Endocrinol Metab. 1999 Apr;84(4):1174-83
pubmed: 10199749
Br Med Bull. 1981 Sep;37(3):233-8
pubmed: 7034846
J Clin Endocrinol Metab. 2008 Feb;93(2):352-7
pubmed: 18000092

Auteurs

Jan M. Wit (JM)

Leiden University Medical Center, Department of Paediatrics, Leiden, The Netherlands

Theo C. J. Sas (TCJ)

Sophia Children’s Hospital, University Medical Center Rotterdam, Department of Paediatric Endocrinology; National Diabetes Care and Research Center, Clinic of Diabetes, Rotterdam, The Netherlands

Michael B. Ranke (MB)

University Children’s Hospital, Tübingen, Germany

Paula van Dommelen (P)

The Netherlands Organization for Applied Scientific Research TNO, Leiden, The Netherlands

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH